Marketing Worldwide (MWWC) Stock Keeps On Hitting New Highs: But Why?

Every day thousands of investors look into the possibility of investing in the...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Cara Therapeutics CARA Stock Price, are you serious?...
Nascent Biotech NBIO Stock Price is ready for anothe...
CytoDyn Inc. CYDY Stock Price is so consistent, can ...

Every day thousands of investors look into the possibility of investing in the next big thing from among micro-cap stocks and one of the stocks from that category of stocks to have come into prominence in recent days is that of Marketing Worldwide Corp (OTCMKTS:MWWC).

Investors piled on to the Marketing Worldwide Corp stock in a big way last week and the stock ended up clocking gains of as much as 230%. In light of the massive gains made by the stock last week, it might be a good move for investors to look into the stock a bit more closely. One of the things that ought to be mentioned in relation to the rally in the Marketing Worldwide Corp stock is that the stock has become very popular on the social media platform Twitter.

As is well known, social media chatter has increasingly become a significant factor in triggering strong rallies in micro-cap stocks. On the other hand, it has also emerged that the Marketing Worldwide stock is on the radars of some of the biggest investors in the micro-cap space and that could be another reason why the stock could continue to garner attention from investors this week as well. At this point in time, the stock is one of the most searched stocks online and that reflects the rising interest in it. It seems that the stock is looking to go on a similar run as some of the other major micro-cap gainers like Tesoro and Enzolytics among others.

Stay in the lopp :

Here's Who Just Picked Up Eleven Biotherapeut...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Eleven Biotherapeutics Inc. (NASDAQ:EBIO) reported that Flagship Ventures Fund 2007,
Elliott Associates is Buying Advisory Board C...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Advisory Board Co. (NASDAQ:ABCO) reported that Elliott Associates, L.p. has
Koios to Complete Development of CBD-Enhance...

Following the Company’s September 4, 2018 announcement of plans to release a functional beverage infused with CBD, Koios has resumed development with test batch production

related post

Skip to content